Malta vs Russia: The number of people with susceptibility test result for rifampicin
Malta
93.1
in 2021
Russia
93.52
in 2021
Malta rank
59th
Russia rank
57th
The number of people with susceptibility test result for rifampicin over time
- Malta
- Russia
How they compare
Russia currently reports 93.52 against 93.1 in Malta, a difference of 0.42.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Malta ahead.
Malta ranks 59th and Russia ranks 57th of 146 countries.
Across the 2 decades both report, Malta averaged higher in 1 and Russia in 1.
Head to head by decade
| Decade | Malta | Russia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 91.41 | 88.47 | 2.94 | Malta |
| 2020s | 90.14 | 93.01 | 2.87 | Russia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Malta or Russia?
- Russia, at 93.52 against 93.1 in Malta as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Malta and Russia?
- 0.42, with Russia ahead.
- How many years of comparable data are there for Malta and Russia?
- 5 years are reported by both, from 2017 to 2021.
- How do Malta and Russia rank globally for the number of people with susceptibility test result for rifampicin?
- Malta ranks 59th and Russia ranks 57th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.